Advances in the Management of Precocious Puberty

Abstract

Get full access to this article

View all access options for this article.

References

Root AW , Schneider J. , and Buserelin Cooperative Study Group. Effectiveness of the gonadotropin-releasing hormone agonist buserelin in the treatment of children with true and complete, central isosexual precocity. Adolesc Pediatr Gynecol. 1991;4:129-135.

Ibañez L. , Virdis R. , Potau N. , et al. Natural history of premature pubarche: an auxological study . J Clin Endocrinol Metab. 1992;74:254-257.

Boepple PA , Crowley WFJr. Gonadotropin-releasing hormone analogues as therapeutic probes in human growth and development: evidence from children with central precocious puberty. Acta Paediatr Scand. 1991 (suppl) ;372: 33-38.

Oerter KE , Manasco P. , Barnes KM , et al. Adult height in precocious puberty after long-term treatment with deslorelin. J Clin Endocrinol Metab. 1991;73: 1235-1240.

Kauli R. , Kornreich L. , Laron Z. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-TRP-6-LHRH. Horm Res . 1990;33:11-17.

Oostdijk W. , Hümmelink R. , Odink Rjh , et al. Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist. Eur J Pediatr. 1990;149:308- 313.

Kreiter M. , Burstein S. , Rosenfield RL , et al. Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr. 1990;117:364-370.

Manasco PK , Pescovitz OH , Feuillan PP , et al. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty. J Clin Endocrine Metab. 1988;67:368-372.

Wheeler MD , Styne DM Drug treat ment of precocious puberty. Drugs 1991;41:717-728.

10.

Pescovitz OH , Comite F. , Hench K. , et al The NIH experience with precocious puberty: diagnostic subgroups and re. sponse to short-term luteinizing hormone releasing hormone analogue therapy. J Pediatr. 1986;108:47-54.

11.

Burton EM , Ball WS Jr, Crone K. , et al. Hamartoma of the tuber cinereum: a comparison of MR and CT findings in four cases. AJWR. 1989;10:497-501.

12.

Starceski PJ , Lee PA , Albright AL , et al. Hypothalamic hamartomas and sexual precocity: evaluation of treatment options. Am J Dis Child. 1990;144:225-228.

13.

Grumbach MM , Kaplan SL Recent advances in the diagnosis and management of sexual precocity. Acta Paediatr Jpn. 1988 ;30(suppl):155-175.

14.

Delemarre-Van De Waal HA , Wennink Jmb , Odink Rjh. Gonadotrophin and growth hormone secretion throughout puberty. Acta Paediatr Scand. 1991 (suppl);372:26-31.

15.

Wheeler MD , Styne DM Diagnosis and management of precocious puberty. Pediatr Clin North Am. 1990;37:1255-1271.

16.

Marshall WA , Tanner JM Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291-303.

17.

Marshall WA , Tanner JM Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13-23.

18.

Bidlingmaier F. , Butenandt O. , Knorr D. Plasma gonadotropins and estrogens in girls with idiopathic precocious puberty. Pediatr Res. 1977;11:91-94.

19.

Brauner R. , Malandry F. , Fontoura M. , et al. Idiopathic central precocious puberty in girls as a model of the effect of plasma estradiol level on growth, skeletal maturation and plasma insulin-like growth factor I. Horm Res. 1991 ;36:116-120.

20.

Greulich W. , Pyle S. Radiologic Atlas of Hand and Wrist. Stanford, CA: Stanford University Press; 1959.

21.

Reiter EO , Kaplan SL , Conte FA , et al. Responsivity of pituitary gonadotropes to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, and precocious adrenarche. Pediatr Res. 1975;9:111-116.

22.

Oerter KE , Uriarte MM , Rose SR , et al. Gonadotropin secretory dynamics during puberty in normal girls and boys. J Clin Endocrinol Metab. 1990;71:1251-1258.

23.

Herman-Giddens ME , Sandler AD , Friedman NE

Sexual precocity in girls: an association with sexual abuse?

Am J Dis Child. 1988;142:431-433.

24.

Parker KL , Baens-Bailon RG , Lee PA Depot leuprolide acetate dosage for sexual precocity. J Clin Endocrinol Metab. 1991;73:50-52.

25.

Belchetz PE , Plant TM , Nakai Y. , et al. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science. 1978:202:631-633.

26.

Cook JS , Doty KL , Conn PM , et al. Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty. J Clin Endocrinol Metab. 1992; 74:1206-1209.

27.

Swaenepoel C. , Chaussain JL , Roger M. Long-term results of long-acting luteinizing-hormone-releasing hormone agonist in central precocious puberty. Horm Res. 1991;36:126-130.

28.

Oostdijk H. , Gevers EF , Drop Sls , et al. Growth and pubertal development during and after treatment with a slow-release gonadotropin-releasing hormone agonist in central precocious puberty. Horm Res. 1991 ;36:121-125.

29.

Laue L. , Kenigsberg D. , Pescovitz OH , et al. Treatment of familial male precocious puberty with spironolactone and testolactone. N Engl J Med. 1989;320: 496-502.

30.

Feuillan PP , Foster CM , Pescovitz OH , et al. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med. 1986;315:1115-1119.

31.

Holland FJ , Fishman L. , Bailey JD , et al. Ketoconazole in the management of precocious puberty not responsive to LHRH- analogue therapy. N Engl J Med. 1985 ;312:1023-1028.

32.

Holland FJ , Kirsch SE , Selby R. Gonadotropin-independent precocious puberty ("testotoxicosis"): influence of maturational status on response to ketoconazole. J Clin Endrocrinol Metab. 1987;64:328-333.

33.

Kauli R. , Pertzelan A. , Prager-Lewin R. , et al. Cyproterone acetate in treatment of precocious puberty. Arch Dis Child. 1976;51:202-208.